Mammalian IAP gene family, primers, probes and detection methods
AssigneeAegera Therapeutics, Inc.
InventorsRobert G. Korneluk, Alexander E. MacKenzie, Stephen Baird, Peter Liston
Life of this patent
Estimating the term…
Abstract
Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
Claims9
A substantially pure polypeptide consisting of a BIR-3 domain having at least 95% sequence identity to SEQ ID NO:24 or SEQ ID NO:25, wherein said polypeptide is capable of inhibiting apoptosis of a mammalian cell when said polypeptide is expressed in said cell.
A substantially pure polypeptide consisting of SEQ ID NO:24 or SEQ ID NO:25, wherein said polypeptide is capable of inhibiting apoptosis of a mammalian cell when said polypeptide is expressed in said cell.
A substantially pure polypeptide comprising SEQ ID NO:24 or SEQ ID NO:25, wherein said polypeptide is capable of inhibiting apoptosis of a mammalian cell when said polypeptide is expressed in said cell.
Dependencies are inferred from the claim text.